Butchko Julia G. has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a sale of 2907 shares of Immunovant, Inc. ($IMVT) on August 21, 2024.
Activity breakdown: 0 open-market purchases and 11 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 21, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2907 | $31.84 | 441,079.0000 | 0 | 0.65% | 0.00% |
| Aug. 21, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 120 | $32.32 | 440,959.0000 | 0 | 0.03% | 0.00% |
| July 17, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2698 | $29.64 | 444,155.0000 | 0 | 0.60% | 0.00% |
| July 17, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 169 | $30.55 | 443,986.0000 | 0 | 0.04% | 0.00% |
| July 9, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 1527 | $28.06 | 446,853.0000 | 0 | 0.34% | 0.00% |
| May 22, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 3247 | $29.65 | 448,380.0000 | 0 | 0.72% | 0.00% |
| April 17, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 7825 | $28.80 | 453,917.0000 | 0 | 1.69% | 0.00% |
| April 17, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2290 | $29.94 | 451,627.0000 | 0 | 0.50% | 0.00% |
| April 9, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 1053 | $31.18 | 461,742.0000 | 0 | 0.23% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | A | Common Stock | 54978 | $0.00 | 462,795.0000 | 0 | 13.48% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | A | Stock Option (right to buy) | 68723 | $0.00 | 68,723.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 2146 | $36.15 | 407,817.0000 | 0 | 0.52% | 0.00% |
| Jan. 5, 2024 | Immunovant, Inc. | $IMVT | Butchko Julia G. | Chief Development Officer | S | Common Stock | 1297 | $38.59 | 409,963.0000 | 0 | 0.32% | 0.00% |